ecancermedicalscience

Research

Defeating cancer with antidepressants

21 Aug 2008
J Lieb

Prostaglandins are ephemeral, infinitesimal signallers self-regulating every cell in the body, including those sub-serving mood and immunity. At first, they were perceived as a master switch, but now are believed to regulate every component of cellular micro-anatomy and physiology, including those of the organelles, cytoskeleton, proteins, enzymes, nucleic acids and mitochondria. Prostaglandins are responsible, paradoxically, for cell function and dysfunction. Excessive prostaglandin synthesis depresses immune function and may induce cancer. An ideal anti-cancer agent would inhibit prostaglandins in such a manner as to shut down the pathogenesis of cancer. In this paper, I will show that antidepressants have such properties.

Related Articles

Matías A Atencio, Elías J Ortega Chahla, Mirko Vidic, Candela V Giuffré, Mickaela Echavarría Demichelis, Joaquín A Luini, Franco E Espinoza, Ana M Rosas, María Cruz Germain, Abril Montani, Iñaki M Dopazo Danieli, Joel A Schernenco, Lucas G Durán, María E Esandi
Patricia N Apenteng, Larry Akoko, Vihar Kotecha, Theresia Mwakyembe, Masumbuko Mwashambwa, Rukia Himid, Deo Hando, Charles Komba, Ally Mwanga, Peter Mbele, Paul Itule, Joshua Jackson, Mungeni Misidai, Cameron Gaskill, Doruk Ozgediz, Nathan Brand
Moushumi Suryavanshi, Prashant Mehta, Manoj Kumar, Saphalta Bhagmar, Vidit Kapoor, Dushyant Kumar, Sweta Mishra, Bhawna Chauhan